Who Paid My Doc
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
ClinicalTrials.gov NCT03155997
Research payments
$28,831,140
Through program year 2025, $28,831,140 in research payments was reported against A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer, across 1,927 payments.
- Paid by (largest first)
- Eli Lilly and Company; Eli Lilly Export S.A. Puerto Rico Branch
- ClinicalTrials.gov
- NCT03155997
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $789,401 | 157 |
| 2024 | Research | $1,334,388 | 226 |
| 2023 | Research | $186 | 1 |
| 2022 | Research | $1,358,646 | 234 |
| 2021 | Research | $3,222,168 | 364 |
| 2020 | Research | $7,537,423 | 410 |
| 2019 | Research | $14,588,928 | 535 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Emmalind Aponte San Antonio, TX Named on 18 payments
- Jay Andersen Tigard, OR Named on 16 payments
- Adam Brufsky Pittsburgh, PA Named on 14 payments
- William Houck Winchester, VA Named on 14 payments
- Vibha Thomas Carrollton, TX Named on 14 payments
- Karen Tedesco Albany, NY Named on 14 payments
- Joyce O'Shaughnessy Dallas, TX Named on 14 payments
- John Wallmark Bethesda, MD Named on 13 payments
- Rachel Swart Tucson, AZ Named on 13 payments
- James Reeves Fort Myers, FL Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.